Clarus Financial Technology

What’s New in CCP Disclosures – 4Q21?

Clearing Houses have published their latest CPMI-IOSCO Quantitative Disclosures:

Background

Under the CPMI-IOSCO Public Quantitative Disclosures, CCPs publish over two hundred quantitative data fields covering margin, default resources, credit risk, collateral, liquidity risk, back-testing and more.

CCPView has over 6 years of these quarterly disclosures for 43 Clearing Houses, each with multiple Clearing Services, covering the period from 30 Sep 2015 to 31 Dec 2021. This disclosure data provides insights into trends over time at one CCP and comparisons between CCPs.

Initial Margin for IRS

IM at major IRS CCPs (usd billions)

IM for IRS staying in the $250-270 billion range for over a year now, seemingly a new plateau and a marked change from the QoQ and YoY increases in the three years from 2017-2019.

Eurex OTC IRS with large IM increases, both QoQ and YoY.

Initial Margin for CDS

IM at major CDS CCPs (usd billions)

Overall CDS IM is flat at $60 billion for this 1-year period.

Initial Margin for ETD

IM at selected ETD CCPs (usd billions)

ETD IM rising QoQ by $37b and YoY by $87b, due to ICE Clear Europe increases of $44b QoQ and $79b, continuing with it’s trend from the prior quarter.

Other Disclosures of Interest

Next let’s do a quick scan of 31-Dec-2021 disclosures, highlighting a few with a change tolerance >10% outside the 3 year range of values:

There are a lot more Clearing Services and Disclosures but I will stop there and leave it to those of you with your own CCPView access to analyze further changes.

As well as a Web UI, we also offer an API to programatically access this data.

IOSCO Quantitative Disclosures

CCPView has disclosures from 43 Clearing Houses, each with many Clearing Services, covering Equities, Bonds, Futures, Options and OTC Derivatives with over 200 quantitative data fields each quarter and quarterly figures from September 2015 to December 2021. That is a lot of data to analyze and inform.

Please contact us if you are interested in subscribing to CCPView.

Stay informed with our FREE newsletter, subscribe here.

Exit mobile version